News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Krognes Steve E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 155 restricted stock units
@ $0 |
|
| 08/23/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,419 shares
@ $22.6, valued at
$32.1k
|
|
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 1,851 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Granted 8,803 options to buy
@ $38.005, valued at
$334.6k
Granted 5,592 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,970 shares
@ $28.44, valued at
$84.5k
|
|
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Granted 7,405 restricted stock units
@ $0
Granted 11,879 options to buy
@ $48.96, valued at
$581.6k
|
|
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
3
| Krognes Steve E. (Director) has filed a Form 3 on Guardant Health, Inc. |
| 06/22/2022 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,000 options to buy
@ $2.22, valued at
$42.2k
|
|
| 02/15/2022 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,560 shares
@ $34.69, valued at
$88.8k
|
|
| 02/11/2022 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,296 shares
@ $37.0931, valued at
$48.1k
|
|
| 01/07/2022 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,225 shares
@ $44.75, valued at
$99.6k
|
|
| 01/05/2022 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 31,000 shares
@ $0
Granted 93,000 options to buy
@ $47.27, valued at
$4.4M
|
|
| 11/19/2021 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Gritstone bio, Inc.|
Txns:
| Granted 19,000 options to buy
@ $9.86, valued at
$187.3k
|
|
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,635 shares
@ $70.174, valued at
$184.9k
Sold 400 shares
@ $71.428, valued at
$28.6k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 14,801 shares
@ $70.099, valued at
$1M
Sold 12,981 shares
@ $70.962, valued at
$921.2k
Sold 8,071 shares
@ $71.992, valued at
$581k
Sold 14,147 shares
@ $73.006, valued at
$1M
|
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2020 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 5,643 shares
@ $0
Paid exercise price by delivering 1,954 shares
@ $32.87, valued at
$64.2k
Exercised 5,643 restricted stock units
@ $0 |
|
| 08/20/2020 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 06/22/2020 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Gritstone Oncology, Inc.|
Txns:
| Granted 12,500 options to buy
@ $6.66, valued at
$83.3k
|
|
| 06/12/2020 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.27, valued at
$49.1k
|
|
| 04/01/2020 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,428 shares
@ $19.48, valued at
$27.8k
|
|
| 04/01/2020 |
4/A
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 4,250 restricted stock units
@ $0 |
|
| 03/23/2020 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2, valued at
$30k
|
|
| 02/12/2020 |
4
| Krognes Steve E. (CFO and Treasurer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 29,143 restricted stock units
@ $0
Granted 136,000 options to buy
@ $24.81, valued at
$3.4M
|
|
|
|
|